Humpath.com - Human pathology

A. Molecular pathology
B. Cellular pathology
C. Tissular pathology
D. Systemic pathology
E. Pathology by systems
F. Pathology by regions
G. Tumoral pathology
H. Case records
J. Books
K. Info - Admin
Resources in pathology
Technical section

Home > D. Systemic pathology > Toxics and drugs > Therapeutics > Targeted therapy > anti-RANKL drugs

anti-RANKL drugs

Monday 2 January 2012

Types

denosumab (Prolia, Xgeva)

See also

targeted therapy

D. Systemic pathology

Immune system diseases
Aging
Endocrine systemic anomalies
Environmental and occupational diseases
Genetic and developmental anomalies
Hematopathology
Infectious diseases
Nutritional diseases
Toxics and drugs
- Therapeutics
  - Targeted therapy
  - Gene therapy
Vascular anomalies

Search:

Also in this section

PARP inhibitor
EGFR inhibitors
KIT inhibitors
anti-RANKL drugs
anti-BRAF drugs
anti-C5 drugs
anti-IL-6 drugs
TNF inhibitors
targeted therapy

1996-2013 Humpath.com - Human pathology
Site Map | Log in | Contact | RSS 2.0

SPIP